D. Jowle

Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1.

L. Aarons, M. Ranson, T. Ward, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer.

Stephen J. Morris, L. Aarons, M. Ranson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lomeguatrib, a Potent Inhibitor of O6-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic Trial and Evaluation in Combination with Temozolomide in Patients with Advanced Solid Tumors

M. Ranson, G. Margison, J. Bridgewater, 2006, Clinical Cancer Research.

Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer

D. Kerr, M. Ranson, D. Ferry, 2004, British Journal of Cancer.